Founded November 2017
Stage Technology development
Investors Trendlines Incubators Israel, private investor
CEO Eran Itzkovitch
Note: Fucoxanthin (few-co-zan-then) is a brown pigment that occurs in the chloroplasts of brown algae.
Marine aquaculture, specifically microalgae, may soon become the principle food source of future generations.
AlgaHealth is developing new microalgal sources for fucoxanthin, a novel microalgae cultivation algorithm (15%-50% more efficient), and processing protocols that will produce large quantities of natural, high-quality fucoxanthin at around 20% of the current costs. The company will develop and produce polysaccharides as a by-product, providing a second source of novel, high-value microalgal products.
With its innovative method for growing microalgae inland and novel microalgal strains, AlgaHealth will produce commercial levels of fucoxanthin at premium quality, to address the large market demand for quality additives and grab this extensive opportunity.
Improved commercial production of Fucoxanthin and polysaccharides in microalgae
Opportunity: AlgaHealth represents the future of marine aquaculture and source of fucoxanthin and polysaccharides. With its innovative method for growing microalgae inland and novel microalgal strains, AlgaHealth will produce commercial levels of premium-quality fucoxanthin to address the large market demand for quality additives and to grab this extensive opportunity.
Request more information about AlgaHealth.
20 years' experience in executive roles and project management including innovation, business development, customer relations, and global operations; A veteran of Israel's defense and energy sectors and former CEO of Abundance Ltd – the largest microalgae facility in Europe and the Middle East
20+ years’ experience in biotech; management positions in R&D and marketing; extensive experience with microalgae, including VP R&D at leading microalgae companies Algatechnologies and Algalo Industries; PhD, biology/chemistry, Weizmann Institute of Science; postdoctorate, Yale University; MBA, Bar-Ilan University
Fucoxanthin and polysaccharides are superfoods found in macro and microalgae that provide significant health and cosmetic benefits. Fucoxanthin supplements were shown to correct metabolic disorders (e.g., obesity, high glucose levels in the blood, insulin resistance) and to prevent cancer. Health applications for polysaccharides include as antiviral agents, ingredients for strengthening the immune system and reducing sugar/insulin levels, and as antioxidants and antiaging materials in cosmetics.
Today, the only source of fucoxanthin is marine macroalgae (seaweed). Yet, the low concentration levels of fucoxanthin in seaweed, combined with the limited seaweed supply, hinders fucoxanthin extraction at commercial levels.
The market for fucoxanthin was $600 million, with a CAGR of 6% (Global Fucoxanthin Market 2015 Industry Trend and Forecast 2020, QY Research 2015). Current prices for pure fucoxanthin range from $40,000 to $80,000 per kilogram.